AOD-9604 5mg
hGH fragment 176-191 analogue
≥99.0%
Third-Party
COA
Also available in 10mg — compare all sizes
Complete your research kit
Also searched as: AOD9604, HGH Frag 176-191 analogue
Third-Party Tested
HPLC & mass spec verified purity
Batch Specific COA
Certificate with every batch
Discreet Packaging
Plain, unbranded, tamper-evident
Same-Day Dispatch
Before 2PM AEST, Australia-wide
AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH), corresponding to amino acids 176–191 with an additional tyrosine residue. AOD-9604 research has primarily focused on metabolic signalling, lipid metabolism and the biological activity associated with this region of the growth hormone molecule. It is supplied as a laboratory research material and should be handled according to appropriate research protocols. Researchers in Australia should confirm batch specifications, analytical documentation and current availability before ordering.
What Is AOD-9604?
AOD-9604 is a modified peptide based on a short fragment of human growth hormone rather than the complete hGH molecule. It was developed to investigate whether particular metabolic activities associated with growth hormone could be studied independently from its broader endocrine effects.
Research has examined AOD-9604 in relation to lipid metabolism and adipose-tissue biology. Early experimental work investigated processes including lipolysis and lipogenesis, although findings from preclinical models should not be interpreted as evidence of established effects in humans.
Key Research Areas
AOD-9604 has attracted research interest in several related areas:
Much of the mechanistic evidence surrounding this peptide originates from experimental or preclinical research. Claims concerning weight loss or other clinical outcomes should therefore be treated separately from laboratory findings.
Why Researchers Study AOD-9604
AOD-9604 is scientifically interesting because it allows researchers to investigate a specific region of the growth hormone molecule without using full-length hGH.
This makes the peptide useful for studying whether biological signalling associated with the 176–191 region can be characterised independently. Research has particularly explored metabolic pathways involving adipose tissue, but AOD-9604 should not be described as producing guaranteed fat-loss, weight-loss or therapeutic outcomes.
Key Research Areas at a Glance
AOD-9604 in Australia
Researchers looking for AOD-9604 Australia suppliers should consider analytical documentation, batch traceability, stated quantity and current stock information rather than price alone.
Before attempting to buy AOD-9604 in Australia, laboratories should verify the supplier’s current product specification, AOD-9604 CoA, testing information, listed price and domestic shipping arrangements. Availability and commercial details should be confirmed directly from the current product listing.
Specifications
Certificate of Analysis
Quality, Purity and Batch Testing
Researchers should evaluate AOD-9604 using product-specific analytical documentation rather than relying solely on general purity statements.
Where available, a batch-specific Certificate of Analysis (CoA) should be reviewed for information such as stated purity, identity testing and analytical methods. HPLC can be used to assess chromatographic purity, while mass spectrometry may support molecular identity verification.
Analytical purity does not demonstrate clinical safety or therapeutic effectiveness.
Storage & Handling
Storage and Laboratory Handling
- Lyophilised storage: Follow the storage conditions specified in the supplier’s batch documentation or product specification.
- After reconstitution: Where validated stability information has not been supplied, researchers should follow their laboratory’s validated protocol and batch-specific documentation.
Unsupported storage temperatures, solvents, reconstitution volumes or stability periods should not be assumed.
Reconstitution calculator: AOD-9604 5mg
Work out concentration and the volume to draw for each aliquot before you add diluent.
- Concentration
- –
- Volume per aliquot
- –
- On a 1 mL (U-100) syringe
- –
- Aliquots per vial
- –
A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.
AOD-9604 5mg: Frequently Asked Questions
AOD-9604 is a synthetic peptide derived from the C-terminal 176–191 region of human growth hormone and developed for experimental research.
Research has examined the peptide's interaction with metabolic processes, particularly mechanisms associated with lipid metabolism and adipose tissue.
No. AOD-9604 is a short modified fragment derived from a specific region of the much larger human growth hormone molecule.
Research has focused mainly on lipid metabolism, adipocyte biology, lipolysis, lipogenesis and related metabolic pathways.
Purity and testing specifications are batch- and supplier-specific. Researchers should consult the relevant analytical documentation before use.
This depends on the supplier and batch. Where provided, researchers should review the batch-specific CoA rather than relying on generic documentation.
Researchers should follow verified storage instructions supplied with the specific batch and their laboratory's established handling procedures.
AOD-9604 may be listed by Australian research-peptide suppliers. Researchers should confirm stock, price, testing, CoA availability and shipping details before ordering.
No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.
Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.
Purchase Other Quantities
AOD-9604 is also available in other vial sizes. Compare the current formats below and jump straight to the quantity that fits your protocol.
Reviews
There are no reviews yet.